Our lab is interested in basic mechanisms, clinical translation, and technology development. We are open to new ideas, perspectives, models, and methodologies, and we seek to tailor the training environment to the individual’s interests, strengths, and areas of growth.

Current/emerging research areas of the lab include:

1. Molecular and cellular subtyping of response to drugs of abuse in co-morbid psychiatric disorders (NIDA DP1)
2. Machine learning-based prediction of adherence to long-acting injectable antipsychotics
3. Epitranscriptomics in brain development and neuropsychiatric disorders
4. Developing biosensors for studying neurobiological mechanisms
5. Spatial mapping of elements in brain diseases, including neurodegeneration
6. Effects of environmental toxicants in neurodevelopmental disorders